Form 4: ADC Therapeutics Director Ron Squarer Receives 40,000 Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Director Ron Squarer received 40,000 restricted stock units (RSUs) as part of the annual grant under the 2019 Equity Incentive Plan.

Summary

  • Ron Squarer, a director of ADC Therapeutics SA, received 40,000 restricted stock units (RSUs) on June 13, 2024.
  • The RSUs were granted under the Issuer's 2019 Equity Incentive Plan as compensation for service as a Director.
  • The RSUs vest one year from the grant date, contingent upon the Reporting Person's continued service to the Issuer.
  • Each RSU represents a contingent right to receive one share of ADC Therapeutics SA's common stock.
  • Following the transaction, Ron Squarer beneficially owns 87,658 common shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard compensation practices and aligns director interests with shareholders.

Positives

  • The grant of RSUs aligns the director's interests with those of the shareholders.
  • The vesting period encourages continued service to the company.

Future Outlook

The RSUs will vest one year from the grant date, contingent upon continued service.

Industry Context

This is a standard practice for compensating board members in publicly traded companies, aligning their interests with shareholders through equity-based compensation.

Comparison to Industry Standards

  • Equity compensation for board members is a common practice across the pharmaceutical and biotechnology industries.
  • Companies like Seagen, Immunogen, and Genmab also utilize stock options and restricted stock units to incentivize and retain their directors.
  • The size of the grant is typical for a company of ADC Therapeutics' size and market capitalization.

Stakeholder Impact

  • The grant of RSUs aligns the director's interests with those of the shareholders, potentially leading to decisions that benefit the company's long-term value.
  • Employees may view this as a positive sign of the company's commitment to its leadership.

Next Steps

  • The RSUs will vest one year from the grant date, subject to continued service.

Key Dates

DateDescription
06/13/2024Date of transaction: grant of 40,000 restricted stock units.
06/14/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.